Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Vivotif Market Growth Potential: How Will Market Size Shift Through 2030?
During the historical timeframe, growth was propelled by a heightened occurrence of typhoid in regions where it is prevalent, an expansion of international journeys to zones with elevated risk, immunization programs initiated by governments, the accessibility of vaccine formulations taken orally, and an increased understanding of public health.
Growth during the projected period is expected due to increasing investments in proactive healthcare, a rising demand for travel-related immunizations, the expansion of immunization coverage for children, a growing emphasis on preventing antimicrobial resistance, and enhanced access to vaccines in developing economies.
Significant developments anticipated in the forecast timeframe include the wider adoption of oral vaccination programs, an increasing need for vaccines for travelers, a greater focus on managing infectious diseases through preventive measures, the expansion of vaccine distribution systems optimized for cold chain, and improved public awareness regarding typhoid prevention.
Get A Free Sample Report With In-Depth Market Insights:
Vivotif Market Development Factors: What’s Supporting Demand?
The rising prevalence of typhoid fever is anticipated to boost the vivotif market’s expansion going forward. This condition, a bacterial infection caused by Salmonella Typhi, transmits via tainted food or water, leading to symptoms such as fever, stomach pain, and exhaustion. Its heightened occurrence is linked to inadequate sanitation, insufficient clean water access, and increasing antimicrobial resistance, especially in less affluent areas. Vivotif contributes to lowering typhoid fever rates by offering a protective oral vaccine targeting Salmonella Typhi, particularly beneficial where sanitation is subpar. For example, GOV.UK, a UK-based government platform, reported in August 2024 that in 2023, around 645 cases of typhoid fever were recorded in England, Wales, and Northern Ireland, an increase from 470 cases in 2022, signaling a consistent year-on-year rise in the disease’s incidence. Consequently, the growing frequency of typhoid fever is stimulating the vivotif market’s expansion.
Vivotif Market Segment Outlook: Which Categories Are Growing Fastest?
The vivotif market covered in this report is segmented –
1) By Clinical Indication: Typhoid, Other Indications
2) By Distribution Channel: Direct Sales, Online Pharmacies, Retail Pharmacies
3) By End-User: Adults, Pediatric
Vivotif Market Leading Companies And Competitive Benchmarking
Major companies operating in the vivotif market are Bavarian Nordic A/S
View The Full Vivotif Market Report:
Vivotif Market Geographic Landscape: Which Region Leads Industry Growth?
Asia-Pacific was the largest region in the vivotif market in 2025. The regions covered in the vivotif market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
